TapewireFind a company

person · Reporting owner

Hutchinson Michael Damon

Disclosed activity across 4 companies

Tapewire entity
15987
SEC CIK
0001606626

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707EVP, Chief Legal Officer & SecMarch 11, 2026March 12, 2026
LivaNova PLCLIVN · Entity 507SVP, CLO and Company SecretaryDecember 15, 2025December 17, 2025
STRYKER CORPSYK · Entity 369VP, Chief Legal OfficerMarch 21, 2019March 25, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

INTEGRA LIFESCIENCES HOLDINGS CORP

Report date March 11, 2026 · Filed March 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct159,911 Reported balance After 2026-03-11 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-03-11 · Grant · Acquired 70,305 · Balance 159,911

F1: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026.

Filing footnotes · ownership attribution and instrument terms

F1: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026.

LivaNova PLC

Report date December 15, 2025 · Filed December 17, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect6,798 Ending reported balance After 2025-12-15 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2025-12-15 · Exercise / conversion · Acquired 2,254 · Balance 7,920

F1: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

Row 2 · 2025-12-15 · Tax withholding · Disposed 1,122 · Balance 6,798

F2: Shares withheld to satisfy tax liability.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect2,253 Reported balance After 2025-12-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2025-12-15 · Exercise / conversion · Disposed 2,254 · Balance 2,253

F3: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the third vesting for which occurred on December 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

F2: Shares withheld to satisfy tax liability.

F3: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the third vesting for which occurred on December 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

STRYKER CORP

Report date March 21, 2019 · Filed March 25, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect14,248 Reported balance After 2019-03-21 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2019-03-21 · Grant · Acquired 7,966 · Balance 14,248

F1: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals.

F2: Includes 473 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2018, the date of the latest available statement of the reporting person's ESPP holdings.

Common StockSEC Table I · non-derivativeDirect10,322 Reported balance After 2019-03-21 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2019-03-21 · Tax withholding · Disposed 3,926 · Balance 10,322

Common StockSEC Table I · non-derivativeDirect6,386 Reported balance After 2019-03-25 transaction · row 3 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 3 · 2019-03-25 · Sale · Disposed 3,936 · Balance 6,386

F3: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.

F4: Represents the average price for transactions in a range from $193.60 to $194.78.

Common StockSEC Table I · non-derivativeIndirectBy 401K678 Reported balance Holding disclosure · report date 2019-03-21 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 678

Filing footnotes · ownership attribution and instrument terms

F1: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals.

F2: Includes 473 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2018, the date of the latest available statement of the reporting person's ESPP holdings.

F3: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.

F4: Represents the average price for transactions in a range from $193.60 to $194.78.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

VARIAN MEDICAL SYSTEMS INC

Report date April 15, 2021 · Filed April 16, 2021

Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2021-04-15 transaction · row 1
1 source row

Row 1 · 2021-04-15 · Disposition to issuer · Disposed 5,589 · Balance 0

F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2021-04-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-04-15 · Disposition to issuer · Disposed 7,204 · Balance 0

F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.

F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 11, 2026 Filed Mar 12, 2026 21:05 UTC INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 GrantRestricted Stock Units · Derivative 70,305 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001606626-26-000004 · wk-form4_1773349536.xml · derivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · EVP, Chief Legal Officer & Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,911

Underlying: Common Stock · 70,305 shares

Expires not disclosed

F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026.

F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 21:24 UTC INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 GrantRestricted Stock Units · Derivative 89,606 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001606626-26-000003 · wk-form4_1770240241.xml · derivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · EVP, Chief Legal Officer & Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,606

Underlying: Common Stock · 89,606 shares

Expires not disclosed

F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 100% on the second anniversary of the grant date of 02/02/2026.

F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 100% on the second anniversary of the grant date of 02/02/2026.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 2,254 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,253

Underlying: Ordinary Shares · 2,254 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the third vesting for which occurred on December 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the third vesting for which occurred on December 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 1,122 $63.06 $70,753.32
Disclosure

SEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,798

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 2,254 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 GrantStock Appreciation Rights · Derivative 19,581 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 9

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,581

Underlying: Ordinary Shares · 19,581 shares

Expires 2035-03-30

F12 · derivative.exercise_date: On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 8,944 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 8

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,944

Underlying: Ordinary Shares · 8,944 shares

Expires not disclosed

F8 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.

F11 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F11 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 4,472 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 7

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,472

Underlying: Ordinary Shares · 4,472 shares

Expires not disclosed

F8 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.

F10 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F10 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 4,472 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 6

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,472

Underlying: Ordinary Shares · 4,472 shares

Expires not disclosed

F8 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.

F9 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F9 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 GrantRestricted Stock Units · Derivative 8,944 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 5

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,944

Underlying: Ordinary Shares · 8,944 shares

Expires not disclosed

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.

F7 · derivative.exercise_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F7 · derivative.expiration_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 1,453 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 4

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,356

Underlying: Ordinary Shares · 1,453 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement.

F5 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F5 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 1,477 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,955

Underlying: Ordinary Shares · 1,477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 1,020 $39.13 $39,912.60
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,666

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
March 30, 2025 Filed Apr 1, 2025 21:00 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 2,930 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000026 · wk-form4_1743555651.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,686

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 17:23 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 2,254 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000151 · wk-form4_1734474186.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,507

Underlying: Ordinary Shares · 2,254 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the second vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the second vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 17:23 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 784 $51.50 $40,376.00
Disclosure

SEC source: 0001639691-24-000151 · wk-form4_1734474186.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,756

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 17:23 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 2,254 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000151 · wk-form4_1734474186.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:18 UTC LivaNova PLC LIVN · Entity 507 GrantStock Appreciation Rights · Derivative 12,700 $0.00 Strike: $55.94 $0.00
Disclosure

SEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 8

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,700

Underlying: Ordinary Shares · 12,700 shares

Expires not disclosed

F10 · derivative.exercise_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F10 · derivative.expiration_date: On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:18 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 2,904 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 7

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,904

Underlying: Ordinary Shares · 2,904 shares

Expires not disclosed

F6 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F9 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F9 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:18 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 2,904 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 6

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,904

Underlying: Ordinary Shares · 2,904 shares

Expires not disclosed

F6 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F8 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting.

F8 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:18 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 5,809 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 5

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,809

Underlying: Ordinary Shares · 5,809 shares

Expires not disclosed

F6 · derivative.exercise_price: Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F7 · derivative.exercise_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F7 · derivative.expiration_date: On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:18 UTC LivaNova PLC LIVN · Entity 507 GrantRestricted Stock Units · Derivative 5,809 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 4

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,809

Underlying: Ordinary Shares · 5,809 shares

Expires not disclosed

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F5 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F5 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:18 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 1,478 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,432

Underlying: Ordinary Shares · 1,478 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F4 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F4 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:18 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 542 $55.94 $30,319.48
Disclosure

SEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,286

F2 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
March 30, 2024 Filed Apr 2, 2024 21:18 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 1,478 $0.00 $0.00
Disclosure

SEC source: 0001639691-24-000044 · wk-form4_1712107124.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in Ordinary Shares of LivaNova PLC (the Company).

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:28 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 2,254 $0.00 $0.00
Disclosure

SEC source: 0001639691-23-000119 · wk-form4_1703021281.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,761

Underlying: Ordinary Shares · 2,254 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting for which occurred on December 15, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting for which occurred on December 15, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F5 · balance_after: This number reflects the number of derivative securities beneficially owned following reported transaction for this specific grant.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:28 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 904 $50.07 $45,263.28
Disclosure

SEC source: 0001639691-23-000119 · wk-form4_1703021281.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,350

F2 · shares: The referenced shares were withheld from distribution to satisfy tax liability.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 16:28 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 2,254 $0.00 $0.00
Disclosure

SEC source: 0001639691-23-000119 · wk-form4_1703021281.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 18:09 UTC LivaNova PLC LIVN · Entity 507 GrantStock Appreciation Rights · Derivative 12,555 $0.00 Strike: $42.71 $0.00
Disclosure

SEC source: 0001639691-23-000033 · wf-form4_168055978873986.xml · derivative · entry 5

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Ordinary Shares · 12,555 shares

Expires not disclosed

F7 · derivative.exercise_date: On March 30, 2023, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting schedule, the first vesting occurring on March 30, 2024. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F7 · derivative.expiration_date: On March 30, 2023, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting schedule, the first vesting occurring on March 30, 2024. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 18:09 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 5,910 $0.00 $0.00
Disclosure

SEC source: 0001639691-23-000033 · wf-form4_168055978873986.xml · derivative · entry 4

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,910

Underlying: Ordinary Shares · 5,910 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F6 · derivative.exercise_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2023 and ending December 31, 2025 relative to the total shareholder return of a peer group of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F6 · derivative.expiration_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2023 and ending December 31, 2025 relative to the total shareholder return of a peer group of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 18:09 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 2,955 $0.00 $0.00
Disclosure

SEC source: 0001639691-23-000033 · wf-form4_168055978873986.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,955

Underlying: Ordinary Shares · 2,955 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F5 · derivative.exercise_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2023-2025 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F5 · derivative.expiration_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2023-2025 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 18:09 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 2,955 $0.00 $0.00
Disclosure

SEC source: 0001639691-23-000033 · wf-form4_168055978873986.xml · derivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,955

Underlying: Ordinary Shares · 2,955 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

F4 · derivative.exercise_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on how the Company's free cash flow (FCF) for performance period 2023-2025 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

F4 · derivative.expiration_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on how the Company's free cash flow (FCF) for performance period 2023-2025 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 18:09 UTC LivaNova PLC LIVN · Entity 507 GrantRestricted Stock Units · Derivative 5,910 $0.00 $0.00
Disclosure

SEC source: 0001639691-23-000033 · wf-form4_168055978873986.xml · derivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,910

Underlying: Ordinary Shares · 5,910 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F2 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting occurring on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F2 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting occurring on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 16:22 UTC LivaNova PLC LIVN · Entity 507 GrantRestricted Stock Units · Derivative 9,015 $0.00 $0.00
Disclosure

SEC source: 0001639691-22-000118 · wf-form4_167148468588807.xml · derivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,015

Underlying: Ordinary Shares · 9,015 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the Plan) and the award agreement.

F2 · derivative.exercise_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting for which will occur on December 15, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F2 · derivative.expiration_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting for which will occur on December 15, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
April 15, 2021 Filed Apr 16, 2021 19:55 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Disposition to issuerRestricted Stock Units · Derivative 7,204 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-013918 · form4.xml · derivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · SVP,Chief Legal Officer, Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,204 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.

F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.

F3 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.

Read SEC document
April 15, 2021 Filed Apr 16, 2021 19:55 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Disposition to issuerCommon Stock 5,589 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-013918 · form4.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · SVP,Chief Legal Officer, Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 15:16 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionRestricted Stock Units · Derivative 11,014 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-030397 · form4.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · SVP,Chief Legal Officer, Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,014 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3 · derivative.exercise_date: Per agreement executed on 24 November 2020, vesting on all outstanding restricted stock unit shares has been accelerated. The restricted stock units originally vested in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023.

F3 · derivative.expiration_date: Per agreement executed on 24 November 2020, vesting on all outstanding restricted stock unit shares has been accelerated. The restricted stock units originally vested in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 15:16 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Tax withholdingCommon Stock 5,425 $174.19 $944,980.75
Disclosure

SEC source: 0001127602-20-030397 · form4.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · SVP,Chief Legal Officer, Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,589

F1 · shares: Represents shares withheld from vested RSUs for the payment of federal, state and payroll taxes due on settlement.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 15:16 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 11,014 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-030397 · form4.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · SVP,Chief Legal Officer, Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,014

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 19:08 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 GrantRestricted Stock Units · Derivative 7,204 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-029975 · form4.xml · derivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · SVP,Chief Legal Officer, Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,204

Underlying: Common Stock · 7,204 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on November 21, 2021, November 21, 2022 and November 21, 2023. Vested shares will be delivered to the reporting person on vest date.

F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on November 21, 2021, November 21, 2022 and November 21, 2023. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
August 21, 2020 Filed Aug 24, 2020 18:34 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 GrantRestricted Stock Units · Derivative 11,014 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-024149 · form4.xml · derivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · SVP,Chief Legal Officer, Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,014

Underlying: Common Stock · 11,014 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023, subject to accelerated vesting in certain circumstances. Vested shares will be delivered to the reporting person on vest date.

F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023, subject to accelerated vesting in certain circumstances. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
March 25, 2019 Filed Mar 25, 2019 21:10 UTC STRYKER CORP SYK · Entity 369 SaleCommon Stock 3,936 $194.10 $763,974.84
Disclosure

SEC source: 0000310764-19-000054 · wf-form4_155354820074109.xml · nonDerivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · VP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,386

F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.

F4 · price: Represents the average price for transactions in a range from $193.60 to $194.78.

Read SEC document
March 21, 2019 Filed Mar 25, 2019 21:10 UTC STRYKER CORP SYK · Entity 369 Tax withholdingCommon Stock 3,926 $197.14 $773,971.64
Disclosure

SEC source: 0000310764-19-000054 · wf-form4_155354820074109.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · VP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,322

Read SEC document
March 21, 2019 Filed Mar 25, 2019 21:10 UTC STRYKER CORP SYK · Entity 369 GrantCommon Stock 7,966 $0.00 $0.00
Disclosure

SEC source: 0000310764-19-000054 · wf-form4_155354820074109.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · VP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,248

F1 · shares: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals.

F1 · price: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals.

F2 · balance_after: Includes 473 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2018, the date of the latest available statement of the reporting person's ESPP holdings.

Read SEC document
February 08, 2019 Filed Feb 8, 2019 21:48 UTC STRYKER CORP SYK · Entity 369 SaleCommon Stock 5,805 $181.09 $1,051,208.87
Disclosure

SEC source: 0000310764-19-000027 · wf-form4_154966250150591.xml · nonDerivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · VP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,282

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.

F4 · price: Represents the average price for transactions in a range from $179.88 to $181.81.

Read SEC document
February 07, 2019 Filed Feb 8, 2019 21:48 UTC STRYKER CORP SYK · Entity 369 SaleCommon Stock 81 $180.14 $14,591.66
Disclosure

SEC source: 0000310764-19-000027 · wf-form4_154966250150591.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · VP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,087

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.

Read SEC document
February 06, 2019 Filed Feb 8, 2019 19:23 UTC STRYKER CORP SYK · Entity 369 GrantEmployee Stock Option granted 02/06/2019 (right to buy) · Derivative 19,515 $179.35 Strike: $179.35 $3,500,015.25
Disclosure

SEC source: 0000310764-19-000020 · wf-form4_154965379265221.xml · derivative · entry 1

Hutchinson Michael David · CIK 0001606626 · VP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,515

Underlying: Common Stock · 19,515 shares

Expires 2029-02-05

F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.

Read SEC document
February 06, 2019 Filed Feb 8, 2019 21:48 UTC STRYKER CORP SYK · Entity 369 SaleCommon Stock 10,109 $180.14 $1,821,075.70
Disclosure

SEC source: 0000310764-19-000027 · wf-form4_154966250150591.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · VP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,168

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.

F2 · price: Represents the average price for transactions in a range from $178.50 to $180.73.

F3 · balance_after: Includes 473 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2018, the date of the latest available statement of the reporting person's ESPP holdings.

Read SEC document
February 05, 2019 Filed Feb 8, 2019 00:26 UTC STRYKER CORP SYK · Entity 369 Exercise / conversionEmployee Stock Option granted 02/23/2010 (right to buy) · Derivative 5,190 $53.09 Strike: $53.09 $275,537.10
Disclosure

SEC source: 0000310764-19-000016 · wf-form4_154958559505795.xml · derivative · entry 5

Hutchinson Michael David · CIK 0001606626 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,190 shares

Expires 2020-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.

Read SEC document
February 05, 2019 Filed Feb 8, 2019 00:26 UTC STRYKER CORP SYK · Entity 369 Exercise / conversionEmployee Stock Option granted 02/10/2009 (right to buy) · Derivative 5,000 $42.00 Strike: $42.00 $210,000.00
Disclosure

SEC source: 0000310764-19-000016 · wf-form4_154958559505795.xml · derivative · entry 4

Hutchinson Michael David · CIK 0001606626 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2019-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.